Economic evaluation of pharmacogenomic-guided antiplatelet treatment in Spanish patients suffering from acute coronary syndrome participating in the U-PGx PREPARE study

被引：0
|
作者：
Margarita-Ioanna Koufaki
Vasileios Fragoulakis
Xando Díaz-Villamarín
Kariofyllis Karamperis
Athanassios Vozikis
Jesse J. Swen
Cristina L. Dávila-Fajardo
Konstantinos Z. Vasileiou
George P. Patrinos
Christina Mitropoulou
机构：
[1] University of Patras School of Health Sciences,Laboratory of Pharmacogenomics and Individualized Therapy, Department of Pharmacy
[2] The Golden Helix Foundation,Laboratory of Health Economics and Management (LabHEM), Economics Department
[3] Instituto de Investigación Biosanitaria de Granada (ibs.Granada),Clinical Pharmacy Department
[4] University of Piraeus,Department of Genetics and Genomics, College of Medicine and Health Sciences
[5] Leiden University Medical Center,Zayed Center for Health Sciences
[6] Hospital Universitario Virgen de las Nieves,undefined
[7] Instituto de Investigación Biosanitaria (ibs.Granada),undefined
[8] United Arab Emirates University,undefined
[9] United Arab Emirates University,undefined
来源：
Human Genomics | / 17卷
关键词：
Clopidogrel; Economic evaluation; Cost-effectiveness; Pharmacogenomics-guided treatment; Spain; Acute coronary syndrome; PREPARE;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 7 条
  • [1] Economic evaluation of pharmacogenomic-guided antiplatelet treatment in Spanish patients suffering from acute coronary syndrome participating in the U-PGx PREPARE study
    Koufaki, Margarita-Ioanna
    Fragoulakis, Vasileios
    Diaz-Villamarin, Xando
    Karamperis, Kariofyllis
    Vozikis, Athanassios
    Swen, Jesse J.
    Davila-Fajardo, Cristina L.
    Vasileiou, Konstantinos Z.
    Patrinos, George P.
    Mitropoulou, Christina
    HUMAN GENOMICS, 2023, 17 (01)
  • [2] Cost-utility analysis and cross-country comparison of pharmacogenomics-guided treatment in colorectal cancer patients participating in the U-PGx PREPARE study
    Fragoulakis, Vasileios
    Roncato, Rossana
    Bignucolo, Alessia
    Patrinos, George P.
    Toffoli, Giuseppe
    Cecchin, Erika
    Mitropoulou, Christina
    PHARMACOLOGICAL RESEARCH, 2023, 197
  • [3] Age and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients undergoing percutaneous coronary intervention: results from the randomized TROPICAL-ACS trial
    Sibbing, Dirk
    Gross, Lisa
    Trenk, Dietmar
    Jacobshagen, Claudius
    Geisler, Tobias
    Hadamitzky, Martin
    Merkely, Bela
    Kiss, Robert Gabor
    Komocsi, Andras
    Parma, Radoslaw
    Felix, Stephan B.
    Neumann, Franz-Josef
    Hausleiter, Joerg
    Baylacher, Monika
    Koltowski, Lukasz
    Mehilli, Julinda
    Huber, Kurt
    Huczek, Zenon
    Aradi, Daniel
    Massberg, Steffen
    EUROPEAN HEART JOURNAL, 2018, 39 (29) : 2749 - +
  • [4] Smoking and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients: a substudy from the randomized TROPICAL-ACS trial
    Orban, Martin
    Trenk, Dietmar
    Geisler, Tobias
    Rieber, Johannes
    Hadamitzky, Martin
    Gross, Lisa
    Orban, Mathias
    Kupka, Danny
    Baylacher, Monika
    Mueller, Susan
    Huber, Kurt
    Koltowski, Lukasz
    Huczek, Zenon
    Heyn, Jens
    Jacobshagen, Claudius
    Aradi, Daniel
    Massberg, Steffen
    Sibbing, Dirk
    Hein, Ralph
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2020, 6 (06) : 372 - 381
  • [5] Diabetes and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients undergoing percutaneous coronary intervention: a pre-specified analysis from the randomised TROPICAL-ACS trial
    Hein, Ralph
    Gross, Lisa
    Aradi, Daniel
    Rieber, Johannes
    Hadamitzky, Martin
    Merkely, Bela
    Huczek, Zenon
    Ince, Hueseyin
    Hummel, Astrid
    Baylacher, Monika
    Massberg, Steffen
    Trenk, Dietmar
    Sibbing, Dirk
    EUROINTERVENTION, 2019, 15 (06) : E513 - +
  • [6] Antiplatelet Therapy Changes for Patients With Myocardial Infarction With Recurrent Ischemic Events: Insights Into Contemporary Practice From the TRANSLATE-ACS (Treatment With ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome) Study
    Fanaroff, Alexander C.
    Kaltenbach, Lisa A.
    Peterson, Eric D.
    Akhter, Mohammed W.
    Effron, Mark B.
    Henry, Timothy D.
    Wang, Tracy Y.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (04):
  • [7] Impact of Routine Fractional Flow Reserve on Management Decision and 1-Year Clinical Outcome of Patients With Acute Coronary Syndromes PRIME-FFR (Insights From the POST-IT [Portuguese Study on the Evaluation of FFR-Guided Treatment of Coronary Disease] and R3F [French FFR Registry] Integrated Multicenter Registries - Implementation of FFR [Fractional Flow Reserve] in Routine Practice)
    Van Belle, Eric
    Baptista, Sergio-Bravo
    Raposo, Luis
    Henderson, John
    Rioufol, Gilles
    Santos, Lino
    Pouillot, Christophe
    Ramos, Ruben
    Cuisset, Thomas
    Cale, Rita
    Teiger, Emmanuel
    Jorge, Elisabete
    Belle, Loic
    Machado, Carina
    Barreau, Didier
    Costa, Marco
    Hanssen, Michel
    Oliveira, Eduardo
    Besnard, Cyril
    Costa, Joao
    Dallongeville, Jean
    Pipa, Joao
    Sideris, Georgios
    Fonseca, Nuno
    Bretelle, Christophe
    Guardado, Jorge
    Lhoest, Nicolas
    Silva, Bruno
    Barnay, Pierre
    Sousa, Maria-Joao
    Leborgne, Laurent
    Silva, Joao Carlos
    Vincent, Flavien
    Rodrigues, Alberto
    Seca, Luis
    Fernandes, Renato
    Dupouy, Patrick
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2017, 10 (06)
1